Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Heckl

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Biomaterials|June 10, 2017
An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA librariesFelix F Adams, Dirk Heckl, Thomas Hoffmann, et al.
Biomaterials|May 11, 2016
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytesVerena Labenski, Julia D Suerth, Elke Barczak, et al.
Nucleic Acids Research|December 22, 2017
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applicationsMaurice Labuhn, Felix F Adams, Michelle Ng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2012
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemiaDirk Heckl, Adrian Schwarzer, Reinhard Haemmerle, et al.
Leukemia|July 1, 2026
Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemiaRobert Winkler, Bruno Griesler, Wolfgang Sippl, et al.
Nature Biotechnology|June 23, 2014
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingDirk Heckl, Monika S Kowalczyk, David Yudovich, et al.
Genome Research|October 3, 2015
Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cellsMonika S Kowalczyk, Itay Tirosh, Dirk Heckl, et al.
Science (New York, N.Y.)|December 17, 2013
Genome-scale CRISPR-Cas9 knockout screening in human cellsOphir Shalem, Neville E Sanjana, Ella Hartenian, et al.
Molecular Therapy. Nucleic Acids|October 15, 2018
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene KnockoutYvonne Knopp, Franziska K Geis, Dirk Heckl, et al.
Blood Advances|January 4, 2018
Gene correction of <i>HAX1</i> reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cellsErik Pittermann, Nico Lachmann, Glenn MacLean, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Biomaterials|June 10, 2017
An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA librariesFelix F Adams, Dirk Heckl, Thomas Hoffmann, et al.
Biomaterials|May 11, 2016
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytesVerena Labenski, Julia D Suerth, Elke Barczak, et al.
Nucleic Acids Research|December 22, 2017
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applicationsMaurice Labuhn, Felix F Adams, Michelle Ng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2012
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemiaDirk Heckl, Adrian Schwarzer, Reinhard Haemmerle, et al.
Leukemia|July 1, 2026
Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemiaRobert Winkler, Bruno Griesler, Wolfgang Sippl, et al.
Nature Biotechnology|June 23, 2014
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingDirk Heckl, Monika S Kowalczyk, David Yudovich, et al.
Genome Research|October 3, 2015
Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cellsMonika S Kowalczyk, Itay Tirosh, Dirk Heckl, et al.
Science (New York, N.Y.)|December 17, 2013
Genome-scale CRISPR-Cas9 knockout screening in human cellsOphir Shalem, Neville E Sanjana, Ella Hartenian, et al.
Molecular Therapy. Nucleic Acids|October 15, 2018
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene KnockoutYvonne Knopp, Franziska K Geis, Dirk Heckl, et al.
Blood Advances|January 4, 2018
Gene correction of <i>HAX1</i> reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cellsErik Pittermann, Nico Lachmann, Glenn MacLean, et al.
Pageof 6